ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.704,45
0,48%
S&P 500
5.480,25
0,13%
US Dollar vs BRL
5,4038
-0,40%
Bitcoin
64.515,23
-2,98%
Brent Oil
84,17
0,32%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Pandion Therapeutics Inc (PAND)

  7. Pandion Therapeutics Inc (PAND) Notícias

PAND

Pandion Therapeutics (PAND)

Pandion Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PAND
DataHoraFonteTítuloCódigoCompanhia
17/05/202117:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PANDPandion Therapeutics Inc
12/04/202107:55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PANDPandion Therapeutics Inc
08/04/202118:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PANDPandion Therapeutics Inc
06/04/202107:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PANDPandion Therapeutics Inc
01/04/202120:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PANDPandion Therapeutics Inc
01/04/202109:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PANDPandion Therapeutics Inc
01/04/202109:47Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PANDPandion Therapeutics Inc
01/04/202109:44Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PANDPandion Therapeutics Inc
01/04/202109:38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PANDPandion Therapeutics Inc
01/04/202109:26Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PANDPandion Therapeutics Inc
31/03/202117:03Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PANDPandion Therapeutics Inc
12/03/202119:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PANDPandion Therapeutics Inc
04/03/202119:16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PANDPandion Therapeutics Inc
04/03/202118:49Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PANDPandion Therapeutics Inc
04/03/202118:35Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PANDPandion Therapeutics Inc
26/02/202118:59Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PANDPandion Therapeutics Inc
26/02/202103:26TipRanksMerck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares SkyrocketNASDAQ:PANDPandion Therapeutics Inc
25/02/202118:02Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PANDPandion Therapeutics Inc
25/02/202111:28Dow Jones NewsPandion Shares More Than Double Premarket on Takeover by MerckNASDAQ:PANDPandion Therapeutics Inc
25/02/202110:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PANDPandion Therapeutics Inc
25/02/202109:28Dow Jones NewsMerck to Buy Pandion Therapeutics for $1.85 BillionNASDAQ:PANDPandion Therapeutics Inc
25/02/202108:45Business WireMerck to Acquire Pandion TherapeuticsNASDAQ:PANDPandion Therapeutics Inc
22/02/202110:30GlobeNewswire Inc.Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoi...NASDAQ:PANDPandion Therapeutics Inc
18/02/202110:30GlobeNewswire Inc.Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:PANDPandion Therapeutics Inc
16/02/202118:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PANDPandion Therapeutics Inc
04/01/202110:00GlobeNewswire Inc.Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expa...NASDAQ:PANDPandion Therapeutics Inc
03/12/202010:00GlobeNewswire Inc.Pandion Therapeutics Appoints Katina Dorton to its Board of DirectorsNASDAQ:PANDPandion Therapeutics Inc
16/11/202018:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PANDPandion Therapeutics Inc
16/11/202018:01GlobeNewswire Inc.Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:PANDPandion Therapeutics Inc
10/11/202010:00GlobeNewswire Inc.Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare ConferenceNASDAQ:PANDPandion Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PAND

Seu Histórico Recente

BOV
C1HK34
Check Point Software Tec...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados